Intravenous urography with a new non-ionic contrast media in a clinical phase III study: Iopentol vs iohexol

The safety and diagnostic efficacy of iopentol 300 mg I/ml were compared with iohexol 300 mg I/ml in 300 patients submitted for urography. The study was carried out as a double-blind, randomised parallel study where 149 patients received iopentol and 150 patients iohexol. There were no significant d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical radiology 1990, Vol.41 (1), p.37-41
Hauptverfasser: Rasmussen, F., Dyreborg, U., Larsen, C., Waaler, A., Tove Kristofferson, D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 41
container_issue 1
container_start_page 37
container_title Clinical radiology
container_volume 41
creator Rasmussen, F.
Dyreborg, U.
Larsen, C.
Waaler, A.
Tove Kristofferson, D.
description The safety and diagnostic efficacy of iopentol 300 mg I/ml were compared with iohexol 300 mg I/ml in 300 patients submitted for urography. The study was carried out as a double-blind, randomised parallel study where 149 patients received iopentol and 150 patients iohexol. There were no significant differences between the patients receiving the two contrast media with regard to demographic parameters, rate of injection or total dose of injected contrast media. No changes in blood pressure and no clinically important changes in heart rate were detected in the two groups. No serious adverse effects occurred. Seven patients (5%) in the iohexol and 12 patients (8%) in the iopentol group experienced adverse effects other than a sensation of warmth. Fourteen iohexol patients (9%) and 18 iopentol patients (12%) experienced warmth related to the contrast injection. Excellent films were obtained in most patients and no difference in diagnostic quality between iopentol and iohexol was observed.
doi_str_mv 10.1016/S0009-9260(05)80930-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79593742</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0009926005809304</els_id><sourcerecordid>79593742</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-37e275faead64c879f26e583648d416eb5648c3c54bd0f1eacac25e344eca3483</originalsourceid><addsrcrecordid>eNqFkE1rGzEQhkVJcJ20PyGgQwnNYROtvnaVSyghbRcMObSB3ISsna1V1tJG2nXif185Nr72pBHvMzPSg9BFSa5LUsqbX4QQVSgqyVcirmqiGCn4BzQvmRQFper5BM2PyEd0ltLf3ZVTPkMzygmXgsxR3_gxmg34MCU8xfAnmmG1xa9uXGGDPbxiH3zhgncW27Bj04jX0DqDnc-E7V2OTI-HlUmAm6bBaZza7S1uwgB-DD3eJOzCCt5C_wmddqZP8PlwnqOn7w-_738Wi8cfzf23RWFZrcaCVUAr0RkwreS2rlRHJYiaSV63vJSwFLmyzAq-bElXgrHGUgGMc7CG8Zqdo8v93CGGlwnSqNcuWeh74yH_U1dKKFZxmkGxB20MKUXo9BDd2sStLoneWdbvlvVOoSZCv1vWPPddHBZMyyzj2HXQmvMvh9ykLKeLxluXjpisWKmUyNjdHoMsY-Mg6mQdeJv1RrCjboP7z0P-ARV2mgc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79593742</pqid></control><display><type>article</type><title>Intravenous urography with a new non-ionic contrast media in a clinical phase III study: Iopentol vs iohexol</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Rasmussen, F. ; Dyreborg, U. ; Larsen, C. ; Waaler, A. ; Tove Kristofferson, D.</creator><creatorcontrib>Rasmussen, F. ; Dyreborg, U. ; Larsen, C. ; Waaler, A. ; Tove Kristofferson, D.</creatorcontrib><description>The safety and diagnostic efficacy of iopentol 300 mg I/ml were compared with iohexol 300 mg I/ml in 300 patients submitted for urography. The study was carried out as a double-blind, randomised parallel study where 149 patients received iopentol and 150 patients iohexol. There were no significant differences between the patients receiving the two contrast media with regard to demographic parameters, rate of injection or total dose of injected contrast media. No changes in blood pressure and no clinically important changes in heart rate were detected in the two groups. No serious adverse effects occurred. Seven patients (5%) in the iohexol and 12 patients (8%) in the iopentol group experienced adverse effects other than a sensation of warmth. Fourteen iohexol patients (9%) and 18 iopentol patients (12%) experienced warmth related to the contrast injection. Excellent films were obtained in most patients and no difference in diagnostic quality between iopentol and iohexol was observed.</description><identifier>ISSN: 0009-9260</identifier><identifier>EISSN: 1365-229X</identifier><identifier>DOI: 10.1016/S0009-9260(05)80930-4</identifier><identifier>PMID: 2404650</identifier><identifier>CODEN: CLRAAG</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>Adult ; Biological and medical sciences ; Contrast Media ; Double-Blind Method ; Female ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Iodobenzoates ; Iohexol ; Male ; Medical sciences ; Radiodiagnosis. Nmr imagery. Nmr spectrometry ; Randomized Controlled Trials as Topic ; Triiodobenzoic Acids ; Urinary system ; Urography</subject><ispartof>Clinical radiology, 1990, Vol.41 (1), p.37-41</ispartof><rights>1990 The Royal College of Radiologists, 38 Portland Place, London W1N 3DG, UK. All rights reserved</rights><rights>1990 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-37e275faead64c879f26e583648d416eb5648c3c54bd0f1eacac25e344eca3483</citedby><cites>FETCH-LOGICAL-c389t-37e275faead64c879f26e583648d416eb5648c3c54bd0f1eacac25e344eca3483</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0009926005809304$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,4010,27900,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=6731995$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2404650$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rasmussen, F.</creatorcontrib><creatorcontrib>Dyreborg, U.</creatorcontrib><creatorcontrib>Larsen, C.</creatorcontrib><creatorcontrib>Waaler, A.</creatorcontrib><creatorcontrib>Tove Kristofferson, D.</creatorcontrib><title>Intravenous urography with a new non-ionic contrast media in a clinical phase III study: Iopentol vs iohexol</title><title>Clinical radiology</title><addtitle>Clin Radiol</addtitle><description>The safety and diagnostic efficacy of iopentol 300 mg I/ml were compared with iohexol 300 mg I/ml in 300 patients submitted for urography. The study was carried out as a double-blind, randomised parallel study where 149 patients received iopentol and 150 patients iohexol. There were no significant differences between the patients receiving the two contrast media with regard to demographic parameters, rate of injection or total dose of injected contrast media. No changes in blood pressure and no clinically important changes in heart rate were detected in the two groups. No serious adverse effects occurred. Seven patients (5%) in the iohexol and 12 patients (8%) in the iopentol group experienced adverse effects other than a sensation of warmth. Fourteen iohexol patients (9%) and 18 iopentol patients (12%) experienced warmth related to the contrast injection. Excellent films were obtained in most patients and no difference in diagnostic quality between iopentol and iohexol was observed.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Contrast Media</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Iodobenzoates</subject><subject>Iohexol</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Radiodiagnosis. Nmr imagery. Nmr spectrometry</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Triiodobenzoic Acids</subject><subject>Urinary system</subject><subject>Urography</subject><issn>0009-9260</issn><issn>1365-229X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1rGzEQhkVJcJ20PyGgQwnNYROtvnaVSyghbRcMObSB3ISsna1V1tJG2nXif185Nr72pBHvMzPSg9BFSa5LUsqbX4QQVSgqyVcirmqiGCn4BzQvmRQFper5BM2PyEd0ltLf3ZVTPkMzygmXgsxR3_gxmg34MCU8xfAnmmG1xa9uXGGDPbxiH3zhgncW27Bj04jX0DqDnc-E7V2OTI-HlUmAm6bBaZza7S1uwgB-DD3eJOzCCt5C_wmddqZP8PlwnqOn7w-_738Wi8cfzf23RWFZrcaCVUAr0RkwreS2rlRHJYiaSV63vJSwFLmyzAq-bElXgrHGUgGMc7CG8Zqdo8v93CGGlwnSqNcuWeh74yH_U1dKKFZxmkGxB20MKUXo9BDd2sStLoneWdbvlvVOoSZCv1vWPPddHBZMyyzj2HXQmvMvh9ykLKeLxluXjpisWKmUyNjdHoMsY-Mg6mQdeJv1RrCjboP7z0P-ARV2mgc</recordid><startdate>1990</startdate><enddate>1990</enddate><creator>Rasmussen, F.</creator><creator>Dyreborg, U.</creator><creator>Larsen, C.</creator><creator>Waaler, A.</creator><creator>Tove Kristofferson, D.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1990</creationdate><title>Intravenous urography with a new non-ionic contrast media in a clinical phase III study: Iopentol vs iohexol</title><author>Rasmussen, F. ; Dyreborg, U. ; Larsen, C. ; Waaler, A. ; Tove Kristofferson, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-37e275faead64c879f26e583648d416eb5648c3c54bd0f1eacac25e344eca3483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Contrast Media</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Iodobenzoates</topic><topic>Iohexol</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Radiodiagnosis. Nmr imagery. Nmr spectrometry</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Triiodobenzoic Acids</topic><topic>Urinary system</topic><topic>Urography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rasmussen, F.</creatorcontrib><creatorcontrib>Dyreborg, U.</creatorcontrib><creatorcontrib>Larsen, C.</creatorcontrib><creatorcontrib>Waaler, A.</creatorcontrib><creatorcontrib>Tove Kristofferson, D.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rasmussen, F.</au><au>Dyreborg, U.</au><au>Larsen, C.</au><au>Waaler, A.</au><au>Tove Kristofferson, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intravenous urography with a new non-ionic contrast media in a clinical phase III study: Iopentol vs iohexol</atitle><jtitle>Clinical radiology</jtitle><addtitle>Clin Radiol</addtitle><date>1990</date><risdate>1990</risdate><volume>41</volume><issue>1</issue><spage>37</spage><epage>41</epage><pages>37-41</pages><issn>0009-9260</issn><eissn>1365-229X</eissn><coden>CLRAAG</coden><abstract>The safety and diagnostic efficacy of iopentol 300 mg I/ml were compared with iohexol 300 mg I/ml in 300 patients submitted for urography. The study was carried out as a double-blind, randomised parallel study where 149 patients received iopentol and 150 patients iohexol. There were no significant differences between the patients receiving the two contrast media with regard to demographic parameters, rate of injection or total dose of injected contrast media. No changes in blood pressure and no clinically important changes in heart rate were detected in the two groups. No serious adverse effects occurred. Seven patients (5%) in the iohexol and 12 patients (8%) in the iopentol group experienced adverse effects other than a sensation of warmth. Fourteen iohexol patients (9%) and 18 iopentol patients (12%) experienced warmth related to the contrast injection. Excellent films were obtained in most patients and no difference in diagnostic quality between iopentol and iohexol was observed.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>2404650</pmid><doi>10.1016/S0009-9260(05)80930-4</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-9260
ispartof Clinical radiology, 1990, Vol.41 (1), p.37-41
issn 0009-9260
1365-229X
language eng
recordid cdi_proquest_miscellaneous_79593742
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Biological and medical sciences
Contrast Media
Double-Blind Method
Female
Humans
Investigative techniques, diagnostic techniques (general aspects)
Iodobenzoates
Iohexol
Male
Medical sciences
Radiodiagnosis. Nmr imagery. Nmr spectrometry
Randomized Controlled Trials as Topic
Triiodobenzoic Acids
Urinary system
Urography
title Intravenous urography with a new non-ionic contrast media in a clinical phase III study: Iopentol vs iohexol
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T16%3A03%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intravenous%20urography%20with%20a%20new%20non-ionic%20contrast%20media%20in%20a%20clinical%20phase%20III%20study:%20Iopentol%20vs%20iohexol&rft.jtitle=Clinical%20radiology&rft.au=Rasmussen,%20F.&rft.date=1990&rft.volume=41&rft.issue=1&rft.spage=37&rft.epage=41&rft.pages=37-41&rft.issn=0009-9260&rft.eissn=1365-229X&rft.coden=CLRAAG&rft_id=info:doi/10.1016/S0009-9260(05)80930-4&rft_dat=%3Cproquest_cross%3E79593742%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79593742&rft_id=info:pmid/2404650&rft_els_id=S0009926005809304&rfr_iscdi=true